Evaluation of anti-obesogenic and anti-diabetic effects of tauroursodeoxycholic acid in Swiss albino rats: possible blockage of CHOP-dependent mitochondrial shuttling of TBP-2 and antagonism of streptozotocin-induced type 2 diabetes
Journal of Chemistry Insights and Discoveries · 2025
DOI: 10.71193/jcid.20250009 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Chemistry Insights and Discoveries, 2025. Verfasst von Aitijjo Bhowmick und 8 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Endoplasmic reticulum (ER) stress plays a critical role in the progression of type 2 diabetes mellitus (T2DM) through activation of the pro-apoptotic transcription factor C/EBP homologous protein (CHOP). Accumulation of CHOP in the nucleus promotes thioredoxin-interacting protein (TXNIP) expression and its translocation to mitochondria, thereby contributing to mitochondrial dysfunction and β-cell loss. Tauroursodeoxycholic acid (TUDCA) and ursodeoxycholic acid (UDCA) are established inhibitors of ER stress–induced CHOP expression. This study evaluated the combined effects of TUDCA and UDCA on body weight regulation and glycemic control in a rat model of T2DM induced by high-fat diet (HFD) feeding and low-dose streptozotocin (STZ). Swiss albino male rats were divided into four groups: control, HFD control, diabetic (HFD+STZ), and treatment [HFD+STZ+TUDCA (0.02%)/UDCA (0.3%)]. Body weight, fasting blood glucose, and postprandial blood glucose were assessed over 90 days. Supplementation with TUDCA and UDCA significantly reduced weight gain and improved glycemic control in diabetic rats (p < 0.0001). The incidence of diabetes was substantially lower in the treatment group compared with untreated diabetic rats, with 0% vs. 50% incidence by day 54 and 34% vs. 75% by day 90. By day 90, PBG levels were significantly lower in treated diabetic rats than in untreated diabetic rats (p < 0.0001). These findings indicate that combined TUDCA and UDCA supplementation exerts strong anti-obesogenic and anti-diabetic effects, enhancing glucose homeostasis and delaying diabetes onset. These findings suggest that blockers of TBP-2 mitochondrial shuttling, such as TUDCA and UDCA, may represent promising strategies for the prevention and treatment of T2DM.
Zitieren
APA
Bhowmick, A., Dutta, K., Hossain, R., Halder, E., Banjerjee, P., Hossain, T., Khatun, M., Sultana, N., & Mandal, M. (2025). Evaluation of anti-obesogenic and anti-diabetic effects of tauroursodeoxycholic acid in Swiss albino rats: possible blockage of CHOP-dependent mitochondrial shuttling of TBP-2 and antagonism of streptozotocin-induced type 2 diabetes. Journal of Chemistry Insights and Discoveries. https://doi.org/10.71193/jcid.20250009
Vancouver
Bhowmick A, Dutta K, Hossain R, Halder E, Banjerjee P, Hossain T, et al. Evaluation of anti-obesogenic and anti-diabetic effects of tauroursodeoxycholic acid in Swiss albino rats: possible blockage of CHOP-dependent mitochondrial shuttling of TBP-2 and antagonism of streptozotocin-induced type 2 diabetes. Journal of Chemistry Insights and Discoveries. 2025. doi:10.71193/jcid.20250009
BibTeX
@article{Bhowmick2025,
author = {Bhowmick, Aitijjo and Dutta, Khokon and Hossain, Ratan and Halder, Esita and Banjerjee, Probir and Hossain, Tofazzal and Khatun, Muslima and Sultana, Nigar and Mandal, Manoj},
title = {Evaluation of anti-obesogenic and anti-diabetic effects of tauroursodeoxycholic acid in Swiss albino rats: possible blockage of CHOP-dependent mitochondrial shuttling of TBP-2 and antagonism of streptozotocin-induced type 2 diabetes},
journal = {Journal of Chemistry Insights and Discoveries},
year = {2025},
doi = {10.71193/jcid.20250009}
}
EUVIMED